Jan 8, 2025 · Medicare drug plans can now cover Eli Lilly 's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday. That opens the door for broader access to Zepbound,...

Jan 9, 2025 · In a statement to CNBC, a spokesperson for the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services, said "current Medicare Part D and Medicaid coverage rules apply" to Zepbound following its landmark approval in December for the most common sleep-related breathing disorder.

Jan 10, 2025 · Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss drugs like Zepbound and Novo Nordisk's Ozempic ...

Jan 3, 2025 · Zepbound is the first medication for obstructive sleep apnea to receive FDA approval . This breakthrough for sleep apnea treatment received FDA approval in December 2024 and can be prescribed to adults who have both obesity and moderate to …

2 days ago · To determine if Zepbound is covered under Medicare, it’s essential to understand the eligibility criteria. Generally, Medicare covers medications that are deemed medically necessary. Here are some key points to consider: You must be 65 years or …

Jan 9, 2025 · The Centers for Medicare and Medicaid Services on Wednesday confirmed that certain Medicare plans can now cover the use of Eli Lilly ’s blockbuster obesity drug Zepbound (tirzepatide) for use in obstructive sleep apnea, according to CNBC.

Jan 10, 2025 · Eli Lilly's weight-loss drug Zepbound just got a huge vote of confidence. The Centers for Medicare & Medicaid Services announced on Wednesday that it will cover the therapy for use in the treatment of sleep apnea with government-backed Medicare insurance plans.

Jan 12, 2025 · CMS announced that Medicare drug plans (Part D or Medicare Advantage) could now cover Zepbound (tirzepatide) when doctors prescribe it to patients for obesity and sleep apnea. This is not the opening of floodgates. It is movement from an absolute “no” to “maybe.”

Medicare drug plans are now allowed to cover Eli Lilly’s blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC on...

Jan 8, 2025 · Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment.